Raymond Tesi
Chief Executive Officer bei INMUNE BIO, INC.
Vermögen: 18 Mio $ am 31.03.2024
Profil
Raymond J.
Tesi was the founder of Fortress Biotech, Inc. founded in 2007, where he served as President & Chief Executive Officer from 2007 to 2010.
Currently, he holds multiple positions including Chairman, President, Chief Executive Officer & CMO at INmune Bio, Inc. since 2015, Director at Bexion Pharmaceuticals, Inc. since 2020, and Director at Savant HWP, Inc. since 2016.
His former positions include Senior VP-Clinical Development & Medical Affairs at SangStat Medical Corp., Vice President-Marketing at Genzyme Corp., Chief Medical Officer at Adienne SRL from 2010 to 2011, and President, Chief Executive & Medical Officer at Fprt Bio Inc from 2011 to 2015.
Dr. Tesi received his doctorate degree from Washington University School of Medicine in 1982.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INMUNE BIO, INC.
8,54% | 19.04.2024 | 1 538 726 ( 8,54% ) | 18 Mio $ | 31.03.2024 |
Aktive Positionen von Raymond Tesi
| Unternehmen | Position | Beginn |
|---|---|---|
| INMUNE BIO, INC. | Chief Executive Officer | 01.09.2015 |
Savant HWP, Inc.
 Savant HWP, Inc. Pharmaceuticals: MajorHealth Technology Savant HWP, Inc. develops and manufactures pharmaceutical products. The American company was founded by Stephen Hurst. | Director/Board Member | 01.12.2016 |
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Director/Board Member | 17.11.2020 |
Ehemalige bekannte Positionen von Raymond Tesi
| Unternehmen | Position | Ende |
|---|---|---|
| Fprt Bio Inc | Chief Executive Officer | 01.05.2015 |
Adienne SRL
 Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Chief Tech/Sci/R&D Officer | 01.10.2011 |
| FORTRESS BIOTECH, INC. | Chief Executive Officer | 01.09.2010 |
| SangStat Medical Corp. | Chief Tech/Sci/R&D Officer | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Ausbildung von Raymond Tesi
| Washington University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| INMUNE BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| SangStat Medical Corp. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Commercial Services |
Savant HWP, Inc.
Savant HWP, Inc. Pharmaceuticals: MajorHealth Technology Savant HWP, Inc. develops and manufactures pharmaceutical products. The American company was founded by Stephen Hurst. | Health Technology |
Adienne SRL
Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Health Technology |
| Fprt Bio Inc |
